Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Merck KGaA (MKKGY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Merck Foundation Together with African and Asian First Ladies Mark 'World Assisted Reproductive Technology Day' 2025 ...

Kai Beckmann, CEO of Electronics at Merck KGaA, discusses Europe's competitiveness in AI development. Trump admin proposes ...

Merck Foundation has pioneered a new era in fertility care across Africa and Asia by training local embryologists and ...

Merck Foundation has produced nearly 30 original songs that speak to infertility, female empowerment, and reproductive rights ...

Merck KGaA (NYSE:MRK) said that the European Commission approved Ezmekly for treating symptomatic, inoperable plexiform ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Merck KGaA has synthesized transcriptional coactivator YAP1/transcriptional enhancer factor (TEAD) and/or TAZ/TEAD interaction inhibitors reported to be useful for the treatment of cancer.

Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...

The scale of the Merck layoffs has not been revealed, but the company indicated that it would target roles in the ...